MEDIPOST conducts the first procedure using the stem cell agent, CARTISTEM.

Mechanism of treatment for cartilage regeneration using stem cells, the first in the world

MEDIPOST publishes stem cell research

MEDIPOST paves way for ‘stem cell era’

‘CARTISTEM’, intensive report on Chicago’s WGN-TV

MEDIPOST recognized as ‘investible’ stem cell firm

Strengthening marketing of ‘CARTISTEM’ by participating in numerous overseas academic conferences

Signed license for ‘CARTISTEM’ in India

Stem cell cartilage differentiation technology Singapore patent

Stem cell treatment ‘CARTISTEM’ patient cutting the 10 million line

US patent for ‘CARTISTEM’ raw material stem cell differentiation capability selection technology

Stem Cell Drug ‘CARTISTEM’ Treatment Japanese Patent